Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The Baska mask is a new supraglottic airway device . The investigators would like to assess its performance in setting in which the current standard - LMA device - is being used.
Our group has performed a number of studies on novel airway devices. In this study we would like to evaluate a new supraglottic airway named Baska mask. We would like to monitor certain parameters (time to and ease of insertion, failure rate, seal pressures, complications etc) as regarding the performance and safety profile of this device. This is a descriptive case series of patients undergoing airway management under general anaesthesia.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Baska | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placement and use of Baska mask | Device | use of a supraglottic airway device as a standard part of a general anaesthetic |
|
| Measure | Description | Time Frame |
|---|---|---|
| Device Placement Success rate | within 30 mins of anaesthesia commencement | |
| time to placement of device | from the moment the device touched until successful ventilation achieved or device removed | within 30 mins of anaesthesia commencement |
| Measure | Description | Time Frame |
|---|---|---|
| airway leak pressure of the device | within 30 mins of anaesthetic commencement | |
| user-rated ease of insertion of device | 10cm visual analog score to be used | within 30 mins of anaestesia commencement |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John G Laffey, FFARCSI | National University of Ireland, Galway and Galway University Hospitals | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Galway University Hospitals | Galway | Galway | Ireland |
Not provided
| ID | Term |
|---|---|
| D016254 | Mutagenesis, Insertional |
| ID | Term |
|---|---|
| D015202 | Protein Engineering |
| D005818 | Genetic Engineering |
| D005821 | Genetic Techniques |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| complication rates | complications specifically monitored will be desaturation episodes, laryngospasm, blood staining of the device, lip damage. We will record other complications related to the use of the device, including but not limited to loss of airway with need to manioulate mask/switch to alternative device, regurgitation, aspiration, teeth damage. | From the moment general anaesthesia commenced up to 1 day postoperatively |
| patient comfort indices | Throat pain, dysphagia and dysphonia will be assessed. 10 point verbal rating scale will be used | from the moment the patient awake up to 1 day postoperatively |
| D009154 |
| Mutation |
| D014644 | Genetic Variation |
| D055614 | Genetic Phenomena |
| D016296 | Mutagenesis |